AstraZeneca COVID vaccine 70% effective vs B117 variant – CIDRAP Original study: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – The Lancet   Commentary on Twitter (thread – Click for more) ASYMPTOMATIC & SYMPTOMATIC Efficacy of Oxford-AstraZeneca #COVID19 vaccine versus #B117 […]

The post AstraZeneca COVID vaccine 70% effective vs. B117 variant appeared first on Links Medicus.